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A
cetylation of lysine is a post-translational modiﬁ-
cation involved in many eukaryotic cellular pro-
cesses (1). Though most commonly associated
with histone proteins (2), a recent proteomic study by
Mann and colleagues identiﬁed nearly 2,000 proteins in
acetylated form and showed that this modiﬁcation is
used globally in regulating cell function (3). This recogni-
tion has motivated a renaming of the histone acetyltrans-
ferase (HAT) and histone deacetylase (HDAC) enzymes to
reﬂect their broader roles [now the lysine acetyltrans-
ferases (KATs) and the lysine deacetylases (KDACs) (4)]
and has highlighted our limited understanding of the
functions of the individual enzymes responsible for
achieving and maintaining acetylation states.
A signiﬁcant effort is now directed at understanding
the differential roles that the 18 human KDAC isoforms
play in regulating cell behavior (5−8). These studies re-
main hampered by a lack of molecular reagents, includ-
ing selective substrates and inhibitors (9), that would
aid in dissecting the roles of the KDACs in cell culture.
In one example, probes were synthesized that structur-
ally mimic the nonselective KDAC inhibitor suberoylani-
lide hydroxamic acid (SAHA) but were modiﬁed to in-
clude a photolinking group (5). The probes were
introduced to cell cultures and lysates and then irradi-
ated with UV light to promote the photo cross-linking to
nearby proteins. The complexes were then isolated us-
ing click chemistry, digested, and analyzed by mass
spectrometry to characterize the expression level of
KDAC1 in cancer cells (5). These probes provide an ex-
cellent tool to identify KDACs and their protein binding
partners but require the discovery of isoform-selective
inhibitors on which to base the design of probes that
can distinguish between isoforms and a substantial ex-
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ABSTRACT This paper reports the development of a class of isoform-selective
peptide substrates for measuring endogenous lysine deacetylase (KDAC) activities
in cell culture. The peptides were ﬁrst identiﬁed by comparing the substrate speci-
ﬁcity proﬁles of the four KDAC isoforms KDAC2, KDAC3, KDAC8, and sirtuin 1
(SIRT1) on a 361-member hexapeptide array wherein the two C-terminal residues
to the acetylated lysine were varied. The arrays were prepared by immobilizing the
peptides to a self-assembled monolayer of alkanethiolates on gold and could
therefore be analyzed by a mass spectrometry technique termed SAMDI (self-
assembled monolayers for matrix assisted laser desorption/ionization time-of-
ﬂight mass spectrometry). Arrays presenting the selective substrates were treated
with nuclear extracts from HeLa, Jurkat, and smooth muscle cells and analyzed to
measure endogenous deacetylase activities. We then use the arrays to proﬁle
KDAC activity through the HeLa cell cycle. We ﬁnd that the activity proﬁle of the
KDAC3 selective peptide closely mirrors the changing acetylation state of the H4
histone, suggesting a role for this enzyme in cell cycle regulation. This work is sig-
niﬁcant because it describes a general route for identifying selective substrates
that can be used to understand the differential roles of members of the deacety-
lase enzyme family in complex biological processes and further because the label-
free approach avoids perturbation of enzyme activity that has plagued
ﬂuorescence-based assays.
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ther, binding of the probe to the enzyme does not verify
that the enzyme is catalytically active. This limitation is
particularly relevant in those cases where protein cofac-
tors are required for activity, such as with KDAC3 (10),
but may still bind the probe absent the cofactor. Addi-
tionally, in vitro deacetylase assay kits are now commer-
cially available, including the Fluor de Lys assay by
Enzo Life Sciences, where tetramer sequences based
on known substrates are coupled with a ﬂuorophore ad-
jacent to the acetylated lysine. Deacetylation renders
the substrate sensitive to trypsin proteolysis which re-
leases the ﬂuorophore and ﬂuorescence is observed.
This and analogous techniques (11) can detect endog-
enous activities in cell lysates but suffer from a lack of
selectivity due to limitations in sequence variation re-
sulting from the location of the ﬂuorophore and there-
fore cannot distinguish activity among the different
isozymes. Though moderate selectivity has been real-
ized by chemically modifying the acetyl position
(12−14), the assays are still subjected to perturbation
of enzyme activity and speciﬁcity that often accompany
these formats (15−19).
Mass spectrometry (MS) provides a label-free format
that overcomes the limitations of label-dependent
deacetylase assays. We previously reported an assay
that uses mass spectrometry to follow the deacetyla-
tion of peptide substrates that are immobilized to self-
assembled monolayers on gold, a technique termed
SAMDI, and therefore avoids the use of radioisotopes
and ﬂuorescent tags common to many in vitro KDAC as-
says (20, 21). We also showed that SAMDI could be
combined with peptide arrays to proﬁle the speciﬁci-
ties of recombinant KDACs (22). In the present work, we
used peptide arrays that vary substrateenzyme inter-
actions beyond the adjacent sites to identify a ﬁrst gen-
eration set of label-free substrates that can distinguish
isoform-selective activities among recombinant KDAC2,
KDAC8, and SIRT1 and can measure endogenous activi-
ties in different cell lines. Finally, we prepared arrays to
proﬁle KDAC activity through the HeLa cell cycle to dem-
onstrate the efﬁcacy of using these substrates to inves-
tigate biological processes.
RESULTS AND DISCUSSION
Peptide Arrays and SAMDI MS Proﬁle KDAC
Speciﬁcity. To identify active substrates for the KDACs,
we ﬁrst synthesized a library of 361 hexapeptides hav-
ing an arginine residue on the N-terminal side of the
acetylated lysine (a favorable interaction for all KDACs
proﬁled here based on our previous work) (22) and a
variable sequence at the two C-terminal residues to the
acetylated lysine: Ac-GRKAcXZC-NH2 where X, Z  all
Figure 1. SAMDI follows the deacetylation of peptides im-
mobilized to maleimide-terminated self-assembled mono-
layers. a) An array of self-assembled monolayers presenting
maleimide groups allows the speciﬁc immobilization of
cysteine-terminated peptides in a uniform orientation and
density. b) The structure of the monolayer and immobilized
peptide and the corresponding SAMDI spectrum after treat-
ment with SIRT1 where X  Tyr. c) A series of representa-
tive SAMDI spectra where a shift of m/z 42 corresponds to a
deacetylation reaction. Red spectra indicate reactions where
SIRT1 showed high activity for the substrate.
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ted onto a maleimide-terminated monolayer to immobi-
lize the peptides in the format of an array, which was
then treated with a KDAC enzyme and analyzed by
SAMDI-MS to determine the degree of deacetylation for
each substrate (Figure 1). Since we know the sequence
of the peptide substrate on each spot in the array, we
could identify the speciﬁc residues that contribute to
activity.
In a ﬁrst example, we treated the peptide array with
KDAC8 and analyzed the array by SAMDI-MS. Consis-
tent with a previous study (22), the array revealed a high
speciﬁcity for the tripeptide motif RKAcF but also demon-
strated that when Phe occupies the Xposition, the Zpo-
sition has little inﬂuence on KDAC8 activity. Indeed, the
most active substrate had Gly in the Zposition, whereas
Glu, Asp, and Gln displayed the lowest activities
(Figure 2, panel a). The SIRT1 ﬁngerprint displayed
speciﬁcity much lower than that of KDAC8 and showed
a preference for those substrates having either Arg or
aromatic residues in the X position. As with KDAC8, the
presence of an acidic residue in the Zsite reduced activ-
ity. This array also revealed that SIRT1 has a general
preference for aromatic residues in the Z position, but
thiseffectdependsontheresidueintheXposition,with
the most active substrates having either basic or hydro-
phobic residues in the X position. Additionally, the fa-
vorable effect of having an aromatic residue in the Zpo-
sition is negated by placement of Pro in the X position,
presumably owing to the bent conformation of this sub-
strate (Figure 2, panel b).
The speciﬁcity proﬁles of KDAC2 and KDAC3/SMRT
are similar in that every substrate for KDAC2 is also a
substrate for KDAC3/SMRT, which is consistent with the
high sequence similarity of the enzymes. KDAC2 pre-
fers Arg, Tyr, or Trp in the X site, but the extent of activ-
ity is inﬂuenced by the Z residue, with Lys, Arg, His, Trp,
Phe,Leu,orGlybeingthemostactive(Figure2,panelc).
The KDAC3/SMRT complex also prefers aromatic resi-
duesintheXorZpositions,especiallyTrp,butislessac-
tive when acidic residues occupy the neighboring site.
This KDAC3 complex is most active toward substrates
having aromatic residues in both the X and Z sites
(Figure 2, panel d). This enzyme is also the least spe-
ciﬁc of those analyzed here in its recognition of
substrates.
The speciﬁcity proﬁles provide a clear view of the se-
quence characteristics that give substrates that are opti-
mally active for each enzyme isoform. We ﬁnd that the
most active substrates presented here, those having an
N-terminal Arg to the acetylated lysine and with basic
and aromatic residues favored at the C-terminal posi-
tion relative to the acetylated lysine, do not mimic many
of the known natural substrates, including histones.
However, this is not surprising since histones make up
only a small percentage of proteins in the acetylome (3),
and we hypothesize that the natural substrates are not
optimized toward deacetylase activity, in order to intro-
duce a mechanism to regulate enzymatic activity. How-
ever, we note that Tyr and Phe were recently found to be
among the most frequently occurring residues adjacent
to acetylated lysines on nonhistone substrates (3), and
arecentstudyidentiﬁedthatestrogen-relatedreceptor
is a substrate for KDAC8, where Lys129 has Arg in the
1 position (24). Therefore, by screening nonbiased
Figure 2. Speciﬁcity ﬁngerprints determined by SAMDI for a) KDAC8, b) SIRT1, c)
KDAC2, and d) KDAC3/SMRT. An array of peptides having sequence Ac-GRKAcXZC-
NH2 was created, where the X and Z residues are shown on the horizontal and
vertical axes, respectively. The degree of deacetylation was determined by SAMDI
and is represented by the gray scale bar.
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quences that may have been overlooked had the de-
sign of the substrates been based on only currently
known substrates, a strategy commonly adopted by
ﬂuorescent-based assays that prevents the detection
of unknown activities. The approach we employ is also
useful for identifying substrates that display selectivity
toward a particular KDAC isoform. These reagents will be
important to measure the activity from different KDAC
isoforms in complex cellular samples, as demonstrated
below, to further our understanding of the differential
roles of these enzymes in cellular behavior.
Identiﬁcation of Isoform-Selective Substrates. On
the basis of the speciﬁcity proﬁles, we selected four
peptides that were optimized for both activity and selec-
tivity toward the set of KDAC2, KDAC8, SIRT1, and
KDAC3/SMRT. The peptides varied only in the identity
of residues at the Xand Zpositions (S5S8 in Table 1).
For comparison, we also evaluate active substrates that
were found in an earlier study (22) that varied the pep-
tide sequence only at the X position (S1S4). We ﬁrst
prepared identical arrays containing S1S4 for use in
proﬁling each KDAC to determine the relative activities
for deacetylation. These proﬁles reveal that peptides
S1S3 have modest selectivity toward KDAC8, SIRT1,
and KDAC2, respectively, but wherein each substrate
has measurable activity by the other enzymes, with
KDAC3/SMRT displaying signiﬁcant activity toward each
of the three peptides (Figure 3, panel a top). Optimiza-
tion of the residue at the Z position gave peptides
S5S8 and led to a substantially improved speciﬁcity
of these peptides (Figure 3, panel a bottom). For ex-
ample, substrate S1 is deacetylated by KDAC8 and
KDAC3/SMRT and partially deacetylated by KDAC2, but
peptide S5 having a Pro in the Z position retained activ-
ity for KDAC8 and KDAC3/SMRT (although to a lesser ex-
tent than KDAC8) but was no longer a substrate for
KDAC2. To clearly deﬁne how selective S5 is for KDAC8,
we calculated a speciﬁcity factor by dividing the activity
of KDAC8 on S5 by the sum of the activities by all en-
zymes (Table 1). Because of the promiscuity of KDAC3/
SMRT, we have calculated a speciﬁcity factor for both
the three-enzyme system (including KDAC2, KDAC8, and
SIRT1) and the four-enzyme system (including all en-
zymes in this study). Similarly, placement of a Val in the
Zsite of S2 gave peptide S6, which was active for SIRT1
but lost its activity for KDAC2 and 8. With peptide S7,
placementofTrpattheZpositionofpeptideS3retained
activity for KDAC2 but lowered activity for KDAC8 and
SIRT1. In each of these cases, KDAC3/SMRT retained ac-
tivity for these peptides, reﬂecting the poor speciﬁcity
of this deacetylase. We did ﬁnd, however, that place-
ment of Arg at the Z site of S4 gave a peptide that had
a higher activity for KDAC3/SMRT (S8) compared with
that of the other KDACs proﬁled (Figure 3, panel b).
Wenextassayedasetofpeptidesthatweredesigned
to determine whether optimization of the residue adja-
cent to the N-terminal Arg (at the 2 position to the
acetylated lysine) would lead to improved activity and
speciﬁcity. We synthesized 54 additional peptides with
substitutions at this position of substrates S5S7 with
each amino acid (excluding cysteine) and found that the
amino acid identity at this position had a less signiﬁ-
cant impact on activity (data not shown). We were un-
able to identify active substrates for KDAC2 or SIRT1 that
lacked activity toward KDAC3/SMRT. In the case of
KDAC8, we found that placement of Asp or Glu in this
position resulted in nearly no activity with KDAC3/SMRT
but also signiﬁcantly reduced KDAC8 activity (Supple-
mentary Figure S1).
Assays of Endogenous KDAC Activity. We used the
SAMDI assay to determine whether our peptide sub-
strates could measure endogenous activities in nuclear
extracts from three cell lines: HeLa, Jurkat, and smooth
muscle cells. We ﬁrst assayed the extracts with a nonse-
lective peptide, Ac-GRKAcYYC-NH2, that was generally
TABLE 1. Peptide substrates for KDAC8,
SIRT1, KDAC2, and KDAC3/SMRT used
in SAMDI assays and speciﬁcity factor
for the three-enzyme system (KDAC2,
KDAC8, and SIRT1) and the four-enzyme
system (all enzymes included)
Peptide Substrate sequence
Speciﬁcity factor
for 3 (4) enzymes
S1 Ac-GRKAcFGC-NH2 0.76 (0.43)
S2 Ac-GRKAcRGC-NH2 0.71 (0.42)
S3 Ac-GRKAcYGC-NH2 0.50 (0.33)
S4 Ac-GRKAcNGC-NH2  (0.43)
S5 Ac-GRKAcFPC-NH2 0.91 (0.57)
S6 Ac-GRKAcRVC-NH2 0.95 (0.50)
S7 Ac-GRKAcYWC-NH2 0.83 (0.47)
S8 Ac-GRKAcNRC-NH2  (0.95)
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proﬁled here. The extracts were applied to a monolayer
presentingthepeptidefor16hat37°Candthenrinsed,
and the monolayers were analyzed by SAMDI to deter-
minethefractionofpeptidethathadbeendeacetylated.
Each of the extracts showed deacetylase activity, with
the greatest activity found with the HeLa extract
(Supplementary Figure S2, panel a), consistent
with the use of this cell line as a source of KDAC ac-
tivity in many deacetylase assays. We then ap-
plied the HeLa extract to peptide arrays present-
ing the selective substrates S5S8. The HeLa
extracts gave efﬁcient deacetylation of peptides
S6, S7, and S8, which suggests the presence of
KDAC2, SIRT1, and KDAC3. Peptide S5, the KDAC8
substrate,wasonlyweaklydeacetylatedcompared
to the other peptides (Figure 4, panel a). To con-
ﬁrm that peptide S6 was deacetylated by SIRT1,
we repeated the reactions with HeLa extracts in the
absence of NAD, and we observed a signiﬁcant
decrease in activity only with the SIRT1-selective
substrate S6 (Figure 4, panel b). Western blot
analysis of the protein expression of these four
KDACs in HeLa extracts shows bands for KDAC2,
KDAC3, and SIRT1, whereas KDAC8 was undetec-
ted (Supplementary Figure S2, panel b), consistent
with the activities determined by SAMDI.
Parallel experiments with extracts from the Jur-
kat and smooth muscle cells gave further evidence
that these substrates could resolve isoform-
speciﬁc deacetylase activities. With the Jurkat cell
line, which demonstrated low levels of general
KDAC activity, the KDAC2 substrate S7 was most
efﬁciently deacetylated, whereas the other three
substrates exhibited minimal deacetylation. Ex-
tracts from smooth muscle cell cultures showed
deacetylationofthepeptidesoptimizedforKDAC2,
SIRT1, and KDAC8, and the KDAC3 substrate was
weakly deacetylated. The detection of KDAC8 activ-
ity is consistent with earlier reports that this iso-
form is highly expressed in this cell type (25) and
consistent with our Western blot analysis (Supple-
mentary Figure S2, panel b). It is important to note
that although the Western blot analysis does not
always correlate to our SAMDI activity proﬁles, this
analytical technique only provides information on
the level of protein expression and not the level of
enzyme activity, which is critical for understanding
the role of individual isozymes in regulating complex
biological behavior.
We then compared the ability of the popular Fluor de
Lys assay to distinguish between endogenous isoform
activities to that of the SAMDI method. We used two
Fluor de Lys substrates that are advertised for a particu-
Figure 3. Identiﬁcation of isoform-selective peptides. a) Active
substrates from the ﬁrst peptide library (top) demonstrate en-
hanced selectivity after changing the residue in the Z position
(bottom). b) An overlay of SAMDI spectra of substrates S5S8
treated with KDAC2, KDAC8, SIRT1, and KDAC3/SMRT demon-
strate the selectivity of each peptide substrate. Deacetylase ac-
tivity is indicated by the red arrow.
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SIRT1 (RHKKAc-FdL; KI-177). We observed ﬂuorescence
on both substrates upon treatment with HeLa nuclear
extracts (data not shown), which could be interpreted
to mean that the extracts contain both KDAC8 and
SIRT1, a conclusion that contradicts the results from
both SAMDI and Western blot analysis. Furthermore, re-
cent reports have shown that these substrates are not
active toward their respective enzymes absent the ﬂu-
orophore (19, 22) and that the presence of the ﬂuoro-
phorecansigniﬁcantlyaltertheeffectofpotentialinhibi-
tors and activators (18). Taken together, these results
further demonstrate the importance of using a label-free
activity assay, which can optimize substrates for activ-
ity and selectivity, for investigating this family of
enzymes.
KDAC Activity through the Cell Cycle. Acetylation is
an important post-translational modiﬁcation involved
in cell cycle regulation. Recent evidence has shown that
histones are hypoacetylated during mitosis (26−31)
and treatment of cells with nonselective KDAC inhibi-
tors leads to cell cycle arrest at G2/M (32). These re-
ports suggest that the KDAC enzyme family is involved
in cell cycle maintenance, but there is a lack of suitable
methods to directly observe the activity of the enzyme
family and identify which isoforms are responsible for
maintaining key acetylation states. Common strategies
to detect acetylation rely on antibodies that bind to
acetylated lysines, and this allows a comparison be-
tween acetylation states in different cellular samples
(33). Mass spectrometry that incorporates SILAC tech-
nology (34) has been successful in quantifying acetyla-
tion patterns through cell cycle (30) but lacks the ability
to identify which enzymes are active and responsible
for the observed acetylation states. Studying individual
enzymes using knockout strategies (35, 36) is informa-
tive, yet it is unclear whether a change in acetylation
state or phenotype is due to the loss of speciﬁc activity
orakeyproteinproteininteractionandcannotaccount
for enzyme redundancy. Here we demonstrate the abil-
ity of SAMDI to monitor activity in a complex biological
process by measuring KDAC activity through the HeLa
cell cycle using a combination of the selective and non-
selective reagents described above.
In a ﬁrst example, we treated HeLa cells with thymi-
dine and nocodazole to arrest them in the G1/S phase
and the G2/M phase, respectively, and we then ana-
lyzed the DNA content of the cells by ﬂow cytometry us-
ing propidium iodide to conﬁrm that the majority of
cells were in the expected phase (Figure 5, panel a).
We then isolated and applied the nuclear extracts from
the two cellular conditions at a total protein concentra-
tion of 1 mg mL1 to a peptide array presenting a series
of nonselective KDAC substrates (Ac-GRKAcYYC-NH2, Ac-
GRKAcWRC-NH2, Ac-GRKAcWTC-NH2, Ac-GRKAcYRC-NH2,
and Ac-GRKAcRWC-NH2). The SAMDI spectra show higher
KDACactivityinthesamplesisolatedintheG2/Mphase
(Figure 5, panels b and c), consistent with literature re-
ports of hypoacetylated histones during G2/M (26−30).
To supplement these results we compared the G1/S-
and G2/M-arrested cells using an antibody against
acetylated H4 by Western blot of nuclear extracts and
immunoﬂuorescence of adherent cells. We observe a
lower level of acetylated histone H4 in the G2/M phase
cells compared to G1/S with Western blot analysis
(Figure 5, panel d) and with immunoﬂuorescence
(Figure 5, panel e).
Figure 4. Measurement of endogenous KDAC activity using
SAMDI. a) Nuclear extracts (NE) from HeLa, Jurkat, and
smooth muscle cells were applied to arrays presenting the
selective substrates and analyzed by SAMDI. b) Treat-
ment of HeLa nuclear extracts on the selective substrates
in the absence of NAD, the required cofactor for SIRT1
activity, causes a decrease in deacetylation of the SIRT1
substrate.
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tivity through the cell cycle. We synchronized the cells
in the G1/S phase with thymidine, released the cells
from the thymidine
block, and the cells were
then allowed to proceed
through the cell cycle.
We isolated the nuclear
extracts at 4-h intervals
and analyzed the cell
cycle progression using
ﬂow cytometry with pro-
pidium iodide. After syn-
chronization the majority
of cells are in G1/S
phase (88%). After re-
lease the cells go
through S phase at 4 h
(81%) and G2/M phase
at 8 h (61%), and after
12h,themajorityofcells
are back at G1/S (82%)
(Figure 6, panel a). We
applied the nuclear ex-
tracts to arrays present-
ing a series of nonselec-
tive and selective
substrates and mea-
sured the KDAC activity
using SAMDI. The spec-
tra showed an increase
in KDAC activity at4ha f -
ter thymidine release,
when the cells were
mainly in S phase, and
reached a maximum
peak at 8 h (G2/M
phase), and then the ac-
tivity decreased at the
12 h time point, when
the cells had completed
the cycle and returned to
G1/S (Figure 6, panel b).
Analysis of multiple non-
selective peptides dem-
onstrated that all pep-
tides displayed similar
behavior, although the
degree to which the activity decreased at 12 h varied
slightly (Figure 6, panel c). To determine if our SAMDI
analysis was consistent with the levels of histone H4
Figure 5. KDAC activity is higher during G2/M than G1/S. a) Flow cytometry analysis indi-
cating successful synchronization and segregation of cell populations after treatment of
thymidine (G1/S) and nocodazole (G2/M). b) Representative SAMDI spectra of three nonse-
lective peptides after treatment with nuclear extracts from G1/S (top) and G2/M arrested
cells (bottom). c) SAMDI analysis from 5 nonselective peptides. *p-value 0.05. d) Western
blot analysis of acetylated H4 in G1/S versus G2/M cell populations. e) Immunoﬂuores-
ence of acetylated H4 (red, acetyl-H4; green, actin; blue, nuclei). Scale bar  20 m. Error
bars are standard deviations of the average nuclear ﬂuorescence for 17 (G2/M) and 34
(G1/S) cells.
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extracts with the acetylated H4 antibody and observed
the extent of acetylation using Western blot analysis.
The results show a decrease in acetylation through the












(Figure 7, panel a).
We observe a con-
tinuous increase in
the SAMDI activity
proﬁle for KDAC2, a




(Figure 7, panel b).
Our observation that
acetylation of the H4
histone tail and
KDAC2 activity di-
verge at the 12 h time
point suggests that
either the H4 histone
is not a substrate for
KDAC2 at this particu-
lar time point or that
KDAC2 may not be in-
volved in regulating
the cell cycle, the lat-






G2/M, and then de-
creasesbackatG1/S.
Western blot analysis
of KDAC3 displays a similar pattern, although we note
that this may not directly relate to activity since activity
is dependent on protein cofactors. We therefore ana-
lyzed expression of the cofactor NCOR and observed the
same pattern, supporting the activity proﬁle deter-
Figure 6. KDAC activity monitored during cell cycle. a) Flow cytometry analysis indicating synchronization and cell cycle
progression after release from thymidine block. b) Representative SAMDI spectra from three peptides treated with
nuclear extracts from different phases. c) SAMDI analysis of KDAC activity using 5 nonselective KDAC substrates. *p-
value 0.0005; **p-value 0.005. d) Western blot analysis of H4 acetylation through cell cycle. e) Inverse relationship
between KDAC activity and H4 acetylation through cell cycle.
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matches with the acetylation of the H4 histone tail,
which has been shown to be cell cycle dependent (37),
and therefore suggests that KDAC3 is important in H4
deacetylation and cell cycle maintenance. This result
also supports previous reports that showed that selec-
tive knockdown of KDAC3 but not KDAC1 or KDAC2 re-
sulted in hyperacetylation of H4 and cell cycle arrest in
G2/M(29,39).TheactivityproﬁleofSIRT1appearstore-
semble the general KDAC activity pattern, increasing
through G2/M followed by a decrease at the 12 h time
point, but Western blot analysis shows essentially equal
expression throughout the cell cycle. It is also possible
that the higher activity observed during G2/M with the
SIRT1 substrate is due to overlapping activity by other
isoforms such as KDAC3, as observed above with the re-
combinant enzymes. This ambiguity will be addressed
as more selective substrates are identiﬁed.
This paper addresses the current lack of peptide sub-
strates that are selective for the KDAC isoforms. The use
of SAMDI-MS and peptide arrays is signiﬁcant because
this method does not rely on labels that restrict the pep-
tidesequenceandthereforethedevelopmentofselective
substrates. The arrays allow an efﬁcient proﬁling of hun-
dredsofsubstratesandcanidentifythosesubstratesthat
have the combination of activity and speciﬁcity that will
beimportanttoresolvingthedeactylases.Inadditiontoil-
lustrating the beneﬁts of this approach, this early report
provides a set of peptides that have signiﬁcantly im-
proved speciﬁcity compared with that of the current as-
says,includingthepopularFluordeLysassay.Aswecon-
tinue developing reagents for other members of the KDAC
family, we recognize that it may be difﬁcult to identify
highly selective peptides for each isoform. Rather, we ex-
pectthattheapproachdescribedherewillprovideasetof
peptide substrates that vary in their speciﬁcity for mem-
bers of the KDAC family but as a set provide a high reso-
lution proﬁle of deacetylase activity in the cell. Further
work that develops substrates for other KDACs and fur-
ther optimizes the substrates, through for example the in-
clusion of non-natural amino acids, will provide the mo-
lecular reagents that may have broad value in advancing
the biology of acetylation. This goal parallels the develop-
ment of peptide reagents for proﬁling the caspase family
of proteases, where the reagents are not highly selective
for individual isoforms but nonetheless have been critical
to advancing our understanding of the roles of these en-
zymes in cell function (17, 40).
METHODS
Reagents. All reagents are described in Supporting Informa-
tion, as well as detailed methods for KDAC8 expression, cell cul-
ture, nuclear extract isolation protocols, ﬂow cytometry, immun-
oﬂuorescence, and Western blot analysis.
Synthesis of Peptide Library. Individual lanterns (Mimotopes)
were placed in each well of a 96-well ﬁlter plate, and the ﬁlters
were plugged. The N-terminal ﬂuorenylmethyloxycarbonyl
(FMOC) was deprotected with 20% piperidine in N=,N=-
dimethylformamide (DMF) for 10 min, the solvent was then ﬁl-
tered with a vacuum manifold, and the process was repeated.
The lanterns were then washed 5 times with DMF. A solution
containing 15 mol equiv of amino acid, hydroxybenzotriazole
(HOBt), and diisopropylcarbodiimide (DIC) was prepared, ap-
plied to each well, and incubated at RT for 2 h. The solutions
were then ﬁltered, the lanterns were washed 5 times with DMF,
Figure 7. Selective KDAC activity through cell cycle using
isoform-selective substrates S6S8. a) SAMDI analysis of
KDAC2, SIRT1, and KDAC3 through the HeLa cell cycle.
*p-value 5  106;* * p-value 1  106;# p-value 1
 104. b) Western blot analysis indicating KDAC expres-
sion level through the cell cycle.
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the N-terminus with 10% acetic anhydride in DMF for 30 min, a
cleavage cocktail was applied to the lanterns containing 95% tri-
ﬂuoroacetic acid (TFA), 2.5% H2O, and 2.5% triisopropylsilane
(TIS) and incubated at RT for 2 h. The solutions were then evapo-
rated by ﬂowing nitrogen over the plate for 16 h. The residues
were taken up in water, transferred to a 1.5 mL microcentrifuge
tube, and lyophilized overnight. The remaining solids were then
suspended in deionized ultraﬁltered (DIUF) water with 0.1%
TFA and stored in a 384 plate at 20 °C.
KDAC Assay. (a) SAMDI: Peptide arrays were prepared by ap-
plying 12 L of a 1:1 mixture of the stock peptide solution
with 25 mM Tris pH 7.5 to slides patterned with gold circles (one
peptide per circle) presenting maleimide terminated monolay-
ers (23) and incubated at 37 °C for 1 h for recombinant proteins
and 16 h for nuclear extract treated arrays. Following immobili-
zation, the slides were washed with DIUF water and ethanol and
then dried under nitrogen. KDAC enzymes were diluted, ap-
plied to each circle, and incubated at 37 °C for 1 h (in volumes
of 1 L). The slides were then rinsed with DIUF water and etha-
nol and dried under nitrogen. Monolayers were treated with ma-
trix (2,4,6-trihydroxyacetophenone, 0.01 L, 25 mg mL1 in ac-
etone), air-dried, and analyzed by SAMDI to produce a mass
spectrum for each circle. (b) Fluorescence: The Fluor de Lys As-
say was used according to the manufacturer’s instructions, and
the ﬂuorescence was measured on a Tecan Saﬁre 2 ﬂuorescence
plate reader.
Mass Spectrometry. Mass analysis was performed using a
4800 MALDI-TOF/TOF (Applied Biosystems). A 355 nm Nd:YAG
laser was used as a desorption/ionization source, and all spec-
tra were acquired with 20 kV accelerating voltage using positive
reﬂector mode. The extraction delay was 450 ns, 1200 laser
shots were applied, and the entire surface of the circle was
sampled. Each spectrum was calibrated using the EG3-EG3 disul-
ﬁde background as an internal standard, and the extent of reac-
tion was calculated as previously reported (22).
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